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Classification 
The modified WHO classification distinguishes: 
- endometrioid adenocarcinoma 
- serous carcinoma 
- clear cell carcinoma 
- mucinous carcinoma 
- serous carcinoma 
- mixed types of carcinoma 
- undifferentiated carcinoma 
Clinics and pathology 
Disease 
It is an heterogeneous entity, comprising at least two 
types: 
- type I: endometrioid carcinoma: pre- and 
perimenopausal, estrogen dependent, associated to 
endometrial hyperplasia, low grade, indolent behaviour, 
representing about 80 % of the cases 
- type II: serous carcinoma: post-menopausal, estrogen 
independent, associated to atrophic endometrium, high 
grade, aggressive behaviour, representing about 10 % 
of the cases 
- among other histologic types, type I includes 
mucinous and secretory carcinomas, whereas type II 
includes clear-cell carcinomas and adenosquamous 
carcinomas. 
Embryonic origin 
Tumour developped from the epithelium of the 
endometrial mucosa. 
Etiology 
A strong association between unopposed estrogen 
stimulation and the development of endometrial 
carcinoma has been demonstrated; this may be related 
to replacement estrogen therapy, obesity, or chronic 
anovulation. 
Epidemiology 
It is the most common malignancy of the female genital 
tract in developped countries (33.000 new cases per 




Besides the common sporadic form, there are two 
forms of hereditary endometrial carcinoma: 
- a predisposition to endometrial carcinoma; 
- Lynch syndrome, which associates a risk of colon 
cancer, and ovarian carcinoma in women. 
Cytogenetics 
Cytogenetics Morphological 
The results of conventional cytogenetic techniques and 
Comparative Genomic Hybridisation (CGH) show that 
the two types of endometrial carcinoma differ by their 
karyotypic features: endometrioid carcinomas are 
characterised by relatively simple chromosome 
aberrations whereas serous carcinomas show complex 
abnormalities. 
- Endometrioid carcinomas are generally slightly 
hyperdiploid; chromosome gains concern mainly the 
long arm of chromosome 1 (70 % of the cases) through 
isochromosomes or unbalanced translocations; it can be 
observed as sole abnormality; trisomies 10 (40 % of the 
cases), 2, 7, and 12 are, in decreasing order, the most 
frequently associated abnormalities; trisomy 10 can 
exist as sole imbalance; loss of chromosome 22 has 
also been recurrently observed; Comparative Genomic 
Hybridization (CGH) confirms the low rate of copy  
number changes (mean of 1,5 aberrations per tumour); 
it roughly shows the same imbalances, and, in addition, 
gains of 8q (18 % of cases), and of the region 13q21--
>qter (3 cases); loss of chromosome 22 has not be 
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detected using this method; high level amplification 
was found in 3 cases, in 1q and in 6p. 
- Due to their low incidence and to the complexity of 
their chromosome abnormalities serous carcinomas are 
less documented; a CGH sudy, carried out on 24 case 
showed a higher rate of chromosome imbalances (mean 
of 5,7 aberrations per tumour); the most frequent 
regions of gain were 3q26.1-->qter (50 % of cases), 8q 
(33 %), and 1q, 2q, 5p, 6p; high level amplifications 
were found in 30 % of the cases in 2q, 3q, 5p, 6p, 8q, 
15q, 18 p and 18q, 20. 
- The distinct patterns of chromosome changes 
observed in serous and endometrioid carcinomas 
suggest that these two types belong to two genetic 
entities. A comparison of these results with those of a 
CGH study of serous ovarian carcinoma (cited in 5) 
shows that the serous endometrial carcinoma should be 
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